[1]朱培秋,闫慧敏,赵慧娟,等.MVD基因突变所致不同临床表型的2个汗孔角化症家系[J].中国皮肤性病学杂志,2018,(08):868-872.[doi:10.13735/j.cjdv.1001-089.201801102]
 ZHU Peiqiu,YAN Huimin,ZHAO Huijuan,et al.Different Clinical Phenotypes of Two Chinese Families with Porokeratosis Caused by Mevalonate Diphosphate Decarboxylase(MVD)Gene Mutations[J].The Chinese Journal of Dermatovenereology,2018,(08):868-872.[doi:10.13735/j.cjdv.1001-089.201801102]
点击复制

MVD基因突变所致不同临床表型的2个汗孔角化症家系
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2018年08期
页码:
868-872
栏目:
论著
出版日期:
2018-09-10

文章信息/Info

Title:
Different Clinical Phenotypes of Two Chinese Families with Porokeratosis Caused by Mevalonate Diphosphate Decarboxylase(MVD)Gene Mutations
作者:
朱培秋闫慧敏赵慧娟郭独一姜薇
北京大学第三医院皮肤科,北京 100191
Author(s):
ZHU PeiqiuYAN HuiminZHAO HuijuanGUO DuyiJIANG Wei
Department of Dermatology,Peking University Third Hospital,Beijing 100191,China
关键词:
汗孔角化症 MVD基因突变 临床表现
Keywords:
Porokeratosis MVD gene mutation Clinical manifestation
分类号:
R 758.5
DOI:
10.13735/j.cjdv.1001-089.201801102
文献标志码:
A
摘要:
目的 鉴定2个汗孔角化症家系的致病基因,并分析基因型与临床表型的关系。方法 收集2个汗孔角化症家系的临床资料,提取外周血DNA,针对疾病相关基因测序分析,发现可疑致病性突变位于MVD基因,采用PCR扩增先证者及家系中患者MVD基因13个外显子及其侧翼序列测序验证,并以100例健康人作为对照。 结果 2个家系均符合常染色体显性遗传模式。发现家系1先证者MVD基因第1号外显子的第1位核苷酸A发生突变(c.1A>G),导致氨基酸序列发生错义突变(p.M1V),家系中其他7例患者均带有该突变位点。发现家系2先证者MVD基因第7号外显子的第746号核苷酸T发生突变(c.746T>C),导致氨基酸序列发生错义突变(p.P249S),家系中其他2例患者均带有该突变位点。2个家系突变位点与疾病符合共分离,家系中健康成员及100例健康对照者均未发现相应突变。结论 MVD基因的错义突变(p.M1V; p.P249S)是导致2个家系汗孔角化症发病的特异性突变。
Abstract:
Objective To identify the pathogenic gene mutations in two Chinese families with porokeratosis and analyze their relationship with clinical manifestation. Methods Clinical data of the two families with porokeratosis were collected and genomic DNA was extracted from peripheral blood leukocyte. By sequencing and analyzing the related gene with porokeratosis,the suspicious pathogenic gene was MVD gene. All the 13 coding exons and their flanking sequences of the MVD gene were subjected to PCR for amplifying and DNA sequencing was followed. One hundred normal individuals were also sequenced to exclude single nucleotide polymorphism. Results All the affected members of the first family had a heterozygous A>G substitution at position c.1 in exon 1 of the MVD gene while all the affected members of the second family had a heterozygous T>C substitution at position c.746 in exon 7 of the MVD gene. These mutations were not detected in both normal members of the two families,nor in the 100 healthy controls. Conclusion The heterozygous mutation p.M1V and p.F249S in MVD may cause the clinical manifestation of porokeratosis in the two pedigrees.

参考文献/References:


[1] Zhang Z,Niu Z,Yuan W,et al. Fine mapping and identification of a candidate gene SSH1 in disseminated superficial actinic porokeratosis[J]. Human Mutation,2004,24(5):438.
[2] Zhang Z,Huang W,Niu Z,et al. Two closely linked variations in actin cytoskeleton pathway in a Chinese pedigree with disseminated superficial actinic porokeratosis[J]. JAAD,2005,52(6):972-976.
[3] Zhang ZH,Niu ZM,Yuan WT,et al. A mutation in SART3 gene in a Chinese pedigree with disseminated superficial actinic porokeratosis[J]. BJD,2005,152(4):658-663.
[4] Cui H,Li L,Wang W,et al. Exome sequencing identifies SLC17A9 pathogenic gene in two Chinese pedigrees with disseminated superficial actinic porokeratosis[J].J Med Genet,2014,51(10):699-704.
[5] Zhang Z,Li C,Wu F,et al. Genomic variations of the mevalonate pathway in porokeratosis[J]. Elife,2015,4:e6322.
[6] Sertznig P,von Felbert V,Megahed M. Porokeratosis: present concepts[J]. J Eur Acad Dermatol Venereol,2012,26(4):404-412.
[7] Freyschmidt-Paul P,Hoffmann R,Konig A,et al. Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis: report of two cases exemplifying the concept of type 2 segmental manifestation of autosomal dominant skin disorders[J]. J Am Acad Dermatol,1999,41(4):644-647.
[8] Smit A,Mushegian A. Biosynthesis of isoprenoids via mevalonate in Archaea: the lost pathway[J]. Genome Res,2000,10(10):1468-1484.
[9] Voynova NE,Fu Z,Battaile KP,et al. Human mevalonate diphosphate decarboxylase: characterization,investigation of the mevalonate diphosphate binding site,and crystal structure[J]. Arch Biochem Biophys,2008,480(1):58-67.
[10] Li M,Li Z,Wang J,et al. Mutations in the mevalonate pathway genes in Chinese patients with porokeratosis[J]. J Eur Acad Dermatol Venereol,2016,30(9):1512-1517.
[11] 李秀玲,周倩,朱路得,等. 九例播散性浅表性光化性汗孔角化症患者的临床表型及遗传学分析[J]. 中华医学遗传学杂志,2017,34(4):481-485.
[12] Happle R. Loss of heterozygosity in human skin[J].J Am Acad Dermatol,1999,41(2Pt1):143-164.

相似文献/References:

[1]王健,谢勇,顾明生,等.外阴臀部汗孔角化症误诊为湿疹1例[J].中国皮肤性病学杂志,2016,(06):644.[doi:10.13735/j.cjdv.1001-7089.201503134]
 WANG Jian,XIE Yong,GU Ming-sheng,et al.A Patient of Vulvar Buttock Genitogluteal Porokeratosis Misdiagnosed Eczema[J].The Chinese Journal of Dermatovenereology,2016,(08):644.[doi:10.13735/j.cjdv.1001-7089.201503134]
[2]李秀玲,黄征,童咏花,等.汗孔角化症64例临床与病理分析[J].中国皮肤性病学杂志,2020,(08):894.[doi:10.13735/j.cjdv.1001-7089.201909188]
 LI Xiuling,HUANG Zheng,TONG Yonghua,et al.Clinical and Pathological Analysis of 64 Cases of Porokeratosis[J].The Chinese Journal of Dermatovenereology,2020,(08):894.[doi:10.13735/j.cjdv.1001-7089.201909188]

备注/Memo

备注/Memo:
[基金项目] 国家自然科学基金(81201216)
[作者单位] 北京大学第三医院皮肤科,北京 100191
[通讯作者] 姜薇,E-mail:jiangwei7366@163.com
更新日期/Last Update: 2018-08-01